Literature DB >> 21069426

Differential diagnosis by unenhanced FLAIR T2-weighted magnetic resonance images between solitary high grade gliomas and cerebral metastases appearing as contrast-enhancing cortico-subcortical lesions.

Carmine Franco Muccio1, Annachiara Tarantino, Gennaro Esposito, Alfonso Cerase.   

Abstract

The aim was to assess the value of unenhanced fluid-attenuated inversion recovery T2-weighted sequences (FLAIR-T2) in the differential diagnosis between solitary high-grade gliomas (HGG) and cerebral metastases (CM) appearing as contrast-enhancing cortico-subcortical lesions of the brain. In 69 patients with a contrast-enhancing cortico-subcortical brain lesion (43 HGG, and 26 CM), unenhanced FLAIR-T2 and gadolinium-enhanced FLAIR T1-weighted (Gd-FLAIR-T1) axial images have been reviewed for the involvement of the cortex adjacent to the contrast-enhancing lesion. In 27 (62.79%) out of 43 HGG, and 3 (11.53%) out of 26 CM, the cortex adjacent to the contrast-enhancing lesion showed high signal intensity on unenhanced FLAIR-T2 without enhancement at Gd-FLAIR-T1. Fischer's exact probability test was P = 0.0003 when applied to HGG versus CM categories, indicating a significant difference. The high signal intensity on unenhanced FLAIR-T2 without gadolinium-enhancement of the cortex adjacent to the enhancing lesion is more frequently associated with HGG than CM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21069426     DOI: 10.1007/s11060-010-0454-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  36 in total

1.  A pathology-based substrate for target definition in radiosurgery of brain metastases.

Authors:  Brigitta G Baumert; Isabelle Rutten; Cary Dehing-Oberije; Albert Twijnstra; Miranda J M Dirx; Ria M T L Debougnoux-Huppertz; Philippe Lambin; Bela Kubat
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-07-11       Impact factor: 7.038

2.  Diagnostic value of the fast-FLAIR sequence in MR imaging of intracranial tumors.

Authors:  H W Husstedt; M Sickert; H Köstler; B Haubitz; H Becker
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

3.  The incidence of multifocal cerebral gliomas. A histologic study of large hemisphere sections.

Authors:  R O Barnard; J F Geddes
Journal:  Cancer       Date:  1987-10-01       Impact factor: 6.860

4.  Single Brain Metastasis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2001-01       Impact factor: 3.598

5.  Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions.

Authors:  R Bakshi; S Ariyaratana; R H Benedict; L Jacobs
Journal:  Arch Neurol       Date:  2001-05

6.  Role of advanced MR imaging modalities in diagnosing cerebral gliomas.

Authors:  T Scarabino; T Popolizio; F Trojsi; G Giannatempo; S Pollice; N Maggialetti; A Carriero; A Di Costanzo; G Tedeschi; U Salvolini
Journal:  Radiol Med       Date:  2008-12-11       Impact factor: 3.469

7.  Differentiation of metastases from high-grade gliomas using short echo time 1H spectroscopy.

Authors:  Kirstie S Opstad; Mary M Murphy; Peter R Wilkins; B Anthony Bell; John R Griffiths; Franklyn A Howe
Journal:  J Magn Reson Imaging       Date:  2004-08       Impact factor: 4.813

Review 8.  Advanced MRI of adult brain tumors.

Authors:  Geoffrey S Young
Journal:  Neurol Clin       Date:  2007-11       Impact factor: 3.806

9.  Image fusion of fluid-attenuated inversion recovery magnetic resonance imaging sequences for surgical image guidance.

Authors:  Christopher R Mascott; Lori E Summers
Journal:  Surg Neurol       Date:  2007-06

10.  Detection of brain metastasis: comparison of Turbo-FLAIR imaging, T2-weighted imaging and double-dose gadolinium-enhanced MR imaging.

Authors:  T Okubo; N Hayashi; I Shirouzu; O Abe; S Aoki; A Wada; K Ohtomo; Y Sasaki
Journal:  Radiat Med       Date:  1998 Jul-Aug
View more
  7 in total

Review 1.  Non-Contrast-Enhancing Tumor: A New Frontier in Glioblastoma Research.

Authors:  A Lasocki; F Gaillard
Journal:  AJNR Am J Neuroradiol       Date:  2019-04-04       Impact factor: 3.825

2.  The incidence and significance of multicentric noncontrast-enhancing lesions distant from a histologically-proven glioblastoma.

Authors:  Arian Lasocki; Frank Gaillard; Mark A Tacey; Katharine J Drummond; Stephen L Stuckey
Journal:  J Neurooncol       Date:  2016-07-13       Impact factor: 4.130

Review 3.  Supramarginal Resection for Glioblastoma: It Is Time to Set Boundaries! A Critical Review on a Hot Topic.

Authors:  Francesco Guerrini; Elena Roca; Giannantonio Spena
Journal:  Brain Sci       Date:  2022-05-16

4.  FLAIRectomy: Resecting beyond the Contrast Margin for Glioblastoma.

Authors:  Alexander F Haddad; Jacob S Young; Ramin A Morshed; Mitchel S Berger
Journal:  Brain Sci       Date:  2022-04-25

Review 5.  How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncology.

Authors:  Arian Lasocki; Rodney J Hicks
Journal:  Cancer Imaging       Date:  2019-08-19       Impact factor: 3.909

6.  Exploratory Analysis of Qualitative MR Imaging Features for the Differentiation of Glioblastoma and Brain Metastases.

Authors:  Raphael Meier; Aurélie Pahud de Mortanges; Roland Wiest; Urspeter Knecht
Journal:  Front Oncol       Date:  2020-12-10       Impact factor: 6.244

Review 7.  Immunotherapy of brain metastases: breaking a "dogma".

Authors:  Anna Maria Di Giacomo; Monica Valente; Alfonso Cerase; Maria Fortunata Lofiego; Francesca Piazzini; Luana Calabrò; Elisabetta Gambale; Alessia Covre; Michele Maio
Journal:  J Exp Clin Cancer Res       Date:  2019-10-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.